Return to homepagePandemic Pact

COVID-19 IN RHEUMATOID ARTHRITIS PATIENTS IN IMMUNOSUPPRESSIVE THERAPIES

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $75,000

  • Funder

    Lundbeck Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Rigshospitalet, University of Copenhagen

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This study will investigate whether arthritis patients are at particularly high risk of developing life-threatening complications if they contract COVID-19. A group of arthritis specialists at Rigshospitalet, University of Copenhagen, will therefore study the admission frequency and death rate of arthritis patients as well as the impact of treatment with immunosuppressants on the course of the disease.